Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ralph

Showing results (201-210 of 218) with videos related to

Pageof 22
Sort By:
JAMA Internal Medicine|July 17, 2013
In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditisTahaniyat Lalani, Vivian H Chu, Lawrence P Park, et al.
JAMA|April 4, 2013
Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trialVance G Fowler, Keith B Allen, Edson D Moreira, et al.
The Journal of Infection|April 4, 2009
Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acidDamon P Eisen, G Ralph Corey, Emma S McBryde, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2008
Emergence of coagulase-negative staphylococci as a cause of native valve endocarditisVivian H Chu, Christopher W Woods, Jose M Miro, et al.
Circulation|February 18, 2010
Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection biasTahaniyat Lalani, Christopher H Cabell, Daniel K Benjamin, et al.
Plos One|May 22, 2013
HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohortStephen T Chambers, David Murdoch, Arthur Morris, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogensEthan Rubinstein, Tahaniyat Lalani, G Ralph Corey, et al.
JAMA|June 24, 2005
Staphylococcus aureus endocarditis: a consequence of medical progressVance G Fowler, Jose M Miro, Bruno Hoen, et al.
Archives of Internal Medicine|March 11, 2009
Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort StudyDavid R Murdoch, G Ralph Corey, Bruno Hoen, et al.
The Journal of Infectious Diseases|October 9, 2009
Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significanceIn-Gyu Bae, Jerome J Federspiel, José M Miró, et al.
Pageof 22

Showing results (201-210 of 218) with videos related to

Sort By:
Pageof 22
JAMA Internal Medicine|July 17, 2013
In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditisTahaniyat Lalani, Vivian H Chu, Lawrence P Park, et al.
JAMA|April 4, 2013
Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trialVance G Fowler, Keith B Allen, Edson D Moreira, et al.
The Journal of Infection|April 4, 2009
Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acidDamon P Eisen, G Ralph Corey, Emma S McBryde, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2008
Emergence of coagulase-negative staphylococci as a cause of native valve endocarditisVivian H Chu, Christopher W Woods, Jose M Miro, et al.
Circulation|February 18, 2010
Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection biasTahaniyat Lalani, Christopher H Cabell, Daniel K Benjamin, et al.
Plos One|May 22, 2013
HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohortStephen T Chambers, David Murdoch, Arthur Morris, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogensEthan Rubinstein, Tahaniyat Lalani, G Ralph Corey, et al.
JAMA|June 24, 2005
Staphylococcus aureus endocarditis: a consequence of medical progressVance G Fowler, Jose M Miro, Bruno Hoen, et al.
Archives of Internal Medicine|March 11, 2009
Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort StudyDavid R Murdoch, G Ralph Corey, Bruno Hoen, et al.
The Journal of Infectious Diseases|October 9, 2009
Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significanceIn-Gyu Bae, Jerome J Federspiel, José M Miró, et al.
Pageof 22